Quoin Pharmaceuticals Mission is to Deliver Hope to Those Who Need it Most

QUOIN Pharmaceuticals

Through the Prism takes a closer look at Rare Disease Day, a day that recognizes the challenges faced by the 300 million people around the world who live with a rare disease. In this episode, Quoin Pharmaceuticals (NASDAQ: QNRX) co-founders Michael Myers and Denise Carter, call in to discuss their mission to develop and deliver unique solutions for rare diseases.

Share link:


This communication was produced by Prism MarketView, an affiliate of PCG Advisory Inc., (together “PCG”). PCG is an integrated investor relations, communications and strategic advisory firm. The information contained on this is ‘Paid Advertising’ for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the “Securities Act”). “PCG” and its affiliates are compensated by respective clients for publicizing information relating to its client’s securities. For more information in terms of compensation received for services provided by PCG, see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy…

Read Full Disclaimer

Share This Article


About the Author

Quoin Pharmaceuticals Mission is to Deliver Hope to Those Who Need it Most

Editor Prism MarketView